Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ARDX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Susan Hohenleitner Chief Financial Officer | ARDX Ardelyx, Inc. | Sale | 1,558 | $3.86 | $6,014 Sale | Form 4 ↗ |
| Aug 21, 2026 | James Parker Brady Chief Human Resources Officer | ARDX Ardelyx, Inc. | Sale | 13,160 | $3.86 | $50.8K Sale | Form 4 ↗ |
| Aug 21, 2026 | James Parker Brady Chief Human Resources Officer | ARDX Ardelyx, Inc. | Sale | 1,976 | $3.86 | $7,627 Sale | Form 4 ↗ |
| Aug 21, 2026 | Joseph James Reilly See Remarks | ARDX Ardelyx, Inc. | Sale | 1,110 | $3.86 | $4,285 Sale | Form 4 ↗ |
| Aug 21, 2026 | Joseph James Reilly See Remarks | ARDX Ardelyx, Inc. | Sale | 2,872 | $3.86 | $11.1K Sale | Form 4 ↗ |
| Aug 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 2,575 | $3.86 | $9,940 Sale | Form 4 ↗ |
| Aug 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 3,389 | $3.86 | $13.1K Sale | Form 4 ↗ |
| Aug 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 2,598 | $3.86 | $10.0K Sale | Form 4 ↗ |
| Aug 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 2,002 | $3.86 | $7,728 Sale | Form 4 ↗ |
| Aug 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 2,652 | $3.86 | $10.2K Sale | Form 4 ↗ |
| Aug 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 3,104 | $3.86 | $12.0K Sale | Form 4 ↗ |
| Aug 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 1,734 | $3.86 | $6,693 Sale | Form 4 ↗ |
| Aug 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 2,430 | $3.86 | $9,380 Sale | Form 4 ↗ |
| Aug 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 3,089 | $3.86 | $11.9K Sale | Form 4 ↗ |
| Aug 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 3,486 | $3.86 | $13.5K Sale | Form 4 ↗ |
| Aug 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 19,178 | $3.86 | $74.0K Sale | Form 4 ↗ |
| Aug 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 8,411 | $3.86 | $32.5K Sale | Form 4 ↗ |
| Aug 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 15,976 | $3.86 | $61.7K Sale | Form 4 ↗ |
| Aug 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 15,009 | $3.86 | $57.9K Sale | Form 4 ↗ |
| Aug 21, 2026 | John E. Bishop See Remarks | ARDX Ardelyx, Inc. | Sale | 2,469 | $3.86 | $9,530 Sale | Form 4 ↗ |
| Aug 21, 2026 | John E. Bishop See Remarks | ARDX Ardelyx, Inc. | Sale | 17,281 | $3.86 | $66.7K Sale | Form 4 ↗ |
| Jul 15, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,668 | $5.06 | $210.8K Sale | Form 4 ↗ |
| Jun 18, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 81,898 | $5.99 | $490.6K Sale | Form 4 ↗ |
| Jun 15, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,666 | $5.67 | $236.2K Sale | Form 4 ↗ |
| May 21, 2026 | Susan Hohenleitner Chief Financial Officer | ARDX Ardelyx, Inc. | Sale | 1,455 | $6.27 | $9,123 Sale | Form 4 ↗ |
| May 21, 2026 | James Parker Brady Chief Human Resources Officer | ARDX Ardelyx, Inc. | Sale | 1,846 | $6.27 | $11.6K Sale | Form 4 ↗ |
| May 21, 2026 | Joseph James Reilly See Remarks | ARDX Ardelyx, Inc. | Sale | 1,036 | $6.27 | $6,496 Sale | Form 4 ↗ |
| May 21, 2026 | Joseph James Reilly See Remarks | ARDX Ardelyx, Inc. | Sale | 2,683 | $6.27 | $16.8K Sale | Form 4 ↗ |
| May 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 2,405 | $6.27 | $15.1K Sale | Form 4 ↗ |
| May 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 2,427 | $6.27 | $15.2K Sale | Form 4 ↗ |
| May 21, 2026 | Eric Duane Foster Chief Commercial Officer | ARDX Ardelyx, Inc. | Sale | 3,166 | $6.27 | $19.9K Sale | Form 4 ↗ |
| May 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 2,478 | $6.27 | $15.5K Sale | Form 4 ↗ |
| May 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 1,870 | $6.27 | $11.7K Sale | Form 4 ↗ |
| May 21, 2026 | Mike Kelliher Chief Business Officer | ARDX Ardelyx, Inc. | Sale | 2,900 | $6.27 | $18.2K Sale | Form 4 ↗ |
| May 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 1,418 | $6.27 | $8,891 Sale | Form 4 ↗ |
| May 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 1,911 | $6.27 | $12.0K Sale | Form 4 ↗ |
| May 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 2,157 | $6.27 | $13.5K Sale | Form 4 ↗ |
| May 21, 2026 | Laura A. Williams Chief Patient Officer | ARDX Ardelyx, Inc. | Sale | 1,503 | $6.27 | $9,424 Sale | Form 4 ↗ |
| May 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 14,028 | $6.27 | $88.0K Sale | Form 4 ↗ |
| May 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 17,926 | $6.27 | $112.4K Sale | Form 4 ↗ |
| May 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 7,861 | $6.27 | $49.3K Sale | Form 4 ↗ |
| May 21, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 14,933 | $6.27 | $93.6K Sale | Form 4 ↗ |
| May 21, 2026 | John E. Bishop See Remarks | ARDX Ardelyx, Inc. | Sale | 2,306 | $6.27 | $14.5K Sale | Form 4 ↗ |
| May 15, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,666 | $6.28 | $261.7K Sale | Form 4 ↗ |
| Apr 15, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,668 | $6.29 | $262.1K Sale | Form 4 ↗ |
| Mar 16, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,666 | $5.84 | $243.3K Sale | Form 4 ↗ |
| Feb 24, 2026 | Michael Raab President & CEO, Director | ARDX Ardelyx, Inc. | Sale | 41,666 | $6.26 | $260.8K Sale | Form 4 ↗ |
| Feb 20, 2026 | David M. Mott Director | ARDX Ardelyx, Inc. | Buy | 333,333 | $5.84 | $1.9M Buy | Form 4 ↗ |
| Feb 20, 2026 | John E. Bishop See Remarks | ARDX Ardelyx, Inc. | Sale | 1 | $5.70 | $5.7 Sale | Form 4 ↗ |
| Feb 20, 2026 | John E. Bishop See Remarks | ARDX Ardelyx, Inc. | Sale | 386 | $5.71 | $2,204 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances